STAIDSON
Dead / Cancelled — Cancelled — Section 8 (as of 24 Sept 2021)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86238081
- Registration number
- 4689978
- Mark type
- Stylized text
- Filed
- 01 Apr 2014
- Published for opposition
- 19 Aug 2014
- Registered
- 17 Feb 2015
- Attorney of record
- Alex Patel
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes, for the treatment of injury of optic nerve; Medicines for human purposes, for the treatment of functional constipation and for treatment of intestinal conditions; Medicines for human purposes, for the treatment of diabetes; Medicines for human purposes, for the treatment of acute and chronic inflammatory arthritis, soft tissue rheumatism, soft tissue injury and injury pain; Medicines, namely, acetylsalicylic acid tablets for treatment of antithrombosis and for the treatment of unstable angina; Medicines for human purposes, for the treatment of pruritus and alopecia; Medicines for human purposes, for weight loss; Medicines for human purposes, for treatment of hemostasis; Medicines for human purposes, for the treatment of hepatitis B, Aids, retinal pigment degeneration and glioma; Medicines for human purposes, for the treatment of frequent micturition, urgency of urination and urge urinary incontinence; Supplementary medicines for human purposes, for the treatment of pain of muscle cramp caused by inflammation and injury; Medicines for human purposes, for the treatment of gastric ulcer, duodenal ulcer and chronic gastritis; Medicines for human purposes, for the treatment of infectious disease; Pharmaceutical preparations for the treatment of autoimmune disorders; Medicines for treating constipation
Owner
- Staidson(Beijing) Biopharmaceuticals Co., Ltd., Beijing, CN
- Staidson(Beijing) Biopharmaceuticals Co., Ltd., Beijing, CN
- Staidson(Beijing) Biopharmaceuticals Co., Ltd., Beijing, CN
Prosecution history
- 24 Sept 2021 — CANCELLED SEC. 8 (6-YR)
- 17 Feb 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Feb 2015 — REGISTERED-PRINCIPAL REGISTER
- 16 Jan 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Jan 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Jan 2015 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Nov 2014 — USE AMENDMENT FILED
- 06 Jan 2015 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Nov 2014 — TEAS STATEMENT OF USE RECEIVED
- 14 Oct 2014 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Aug 2014 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Aug 2014 — PUBLISHED FOR OPPOSITION
- 30 Jul 2014 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Jul 2014 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 14 Jul 2014 — APPROVED FOR PUB - PRINCIPAL REGISTER